BioVie Advances the BIV201 Clinical Program and Prefilled Syringe

~ Novel BIV201 Formulation Shows Significant Improvements Over Industry Terlipressin Prefilled Syringe May Significantly Extend Market Protection Beyond Orphan Drug Exclusivity

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.


Please enter your comment!
Please enter your name here